Immuneoncology Market Anticipated to Rise at a Significant CAGR

Immune-oncology Market Anticipated to Rise at a Significant CAGR

06:00 EDT 4 Apr 2019 | Drug Discovery Development

News
Immune-oncology market is driven by manufacturers' emphasis on upgrading immune-oncology drugs as well as increase in R&D to develop anti-cancer drugs.
Contributed Author: 
Radiant Insights, Inc
Topics: 
Pharmaceutical Processing

Original Article: Immune-oncology Market Anticipated to Rise at a Significant CAGR

More From BioPortfolio on "Immune-oncology Market Anticipated to Rise at a Significant CAGR"